Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Moonshot Investor newsletter. To make sure you don’t miss any of Tom’s potential 100x picks, subscribe to his mailing list here . Oil Drops Below $10...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...
Icelandic biotech Alvotech ( NASDAQ: ALVO ) on Thursday said it had started a confirmatory clinical trial for its AVT06 biosimilar candidate to Regeneron's ( REGN ) blockbuster eye injection Eylea. The objective of the study is to compare AVT06 and Eylea in te...
Regeneron to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on August 3, 2022 PR Newswire TARRYTOWN, N.Y. , July 6, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announc...
A deal to allow Medicare health program to negotiate lower prescription drug prices for the elderly have won the backing of all 50 Senate Democrats, Reuters reported Wednesday, citing Senate sources. The deal, which could potentially lower health costs for the U.S. government, was p...
5 Top Health Care Stocks To Watch In The Stock Market Now Even with the holiday-shortened week for the stock market , there remain plenty of data points for investors to consider. Because of this, health care stocks could come into focus. For some context, key market movers in t...
Regeneron Completes Purchase of Sanofi's Stake in Libtayo® (cemiplimab) PR Newswire Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions TARRYTOWN, N.Y. , July 1,...
Should Investors Be Watching These Top Biotech Stocks In The Stock Market Now? Just as most people think that pandemic woes are behind us, we now have the emergence of the monkeypox. While this virus may not be as contagious as the coronavirus, there is still a real cause for concer...
Regeneron Pharmaceuticals ( NASDAQ: REGN ) on Wednesday said the U.S. FDA had accepted its application requesting for an extended regimen for its Eylea injection to treat patients with diabetic retinopathy (DR). DR is when high blood sugar in diabetic patients dam...
EYLEA® (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review PR Newswire If approved, extended regimen would provide a longer treatment interval and additional dosing flexibility, alongside appr...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...